Science News Roundup: U.S. extends environmental review for SpaceX program in Texas; Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many

SpaceX, the space company led by Elon Musk cannot launch the Starship/Super Heavy vehicle until the FAA completes its licensing process, which includes the environmental review. Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many The following is a summary of some recent studies on COVID-19.


Reuters | Updated: 02-10-2021 10:44 IST | Created: 02-10-2021 10:29 IST
Science News Roundup: U.S. extends environmental review for SpaceX program in Texas; Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many
Representative Image Image Credit: Flickr

Following is a summary of current science news briefs.

U.S. extends environmental review for SpaceX program in Texas

The Federal Aviation Administration (FAA) said on Thursday it would extend the public comment period for the draft environmental review of the proposed SpaceX Starship/Super Heavy program in Boca Chica, Texas, to Nov. 1. The extension comes after federal and state agencies participating in the review made the request to extend the period for public input in the environmental assessment. SpaceX, the space company led by Elon Musk cannot launch the Starship/Super Heavy vehicle until the FAA completes its licensing process, which includes the environmental review.

Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Delta variant increases risks for pregnant women

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback